Stromal Cells in Immunity
joint with Fibrosis: From Basic Mechanisms to Targeted Therapies
Organizer(s): Shannon J. Turley, Burkhard Ludewig and Melody A. SwartzDate: February 07 - 11, 2016
Location: Keystone Resort, Keystone, CO, USA
Within lymphoid organs, non-hematopoietic stromal cells organize and interact with leukocytes in immunologically important ways. In addition to organizing T and B cell segregation and expressing lymphocyte survival factors, stromal cells support the migration of and interactions between antigen-presenting cells and naïve T and B cells during the initiation of immune responses and influence the outcome between tolerance and immunity. Recent studies in rodents, non-human primates and humans have demonstrated that stromal cells also play instrumental roles in coordinating immune responses in non-lymphoid tissues, in inflammatory and autoimmune diseases and in chronic infection. Furthermore, stromal cells are being harnessed for therapeutic applications in a number of different clinical indications, an area that holds great promise for improving human health. Our understanding of stromal cell populations and their contributions to innate and adaptive immunity as well as immunological diseases, cancer and vaccination has grown exponentially over the past few years. This emerging field has gained enormous momentum due to highly sophisticated and in-depth efforts to dissect the fundamental biology and clinical importance of this cellular compartment. These critical advances as well as work that is on the cusp of being published or in the pipeline are the focus of this meeting.
Scholarship Deadline: October 8 2015
Discounted Abstract Deadline: October 8 2015
Abstract Deadline: November 10 2015
Discounted Registration Deadline: December 8 2015
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Novartis Institutes for BioMedical Research
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI122597-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.